Skip to content

Clinical trials

Completed Phase 2 Lupus Erythematosus, Systemic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lupus Erythematosus, Systemic Phase: Phase 2 Status: Completed Clear all

98 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20023
20033
20042
20053
20063
20086
20094
20106
20116
20127
20132
20145
20156
20165
20177
20186
20195
20205
20214
20222
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed98

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
MedImmune LLC5
Bristol-Myers Squibb4
UCB Pharma4
AstraZeneca3
National Institute of Allergy and Infectious Diseases (NIAID)3
AbbVie2
Ain Shams University2
Amgen2
Anthera Pharmaceuticals2
Assistance Publique - Hôpitaux de Paris2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lupus Erythematosus, Systemic98
Autoimmune Diseases7
Arthritis, Rheumatoid4
Immune System Diseases4
Lupus Nephritis4
Connective Tissue Diseases3
Sjogren's Syndrome3
Arthritis2
Atherosclerosis2
Cognitive Dysfunction2

Trials

Showing 1 to 25 of 98. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.